4//SEC Filing
Fitzgerald Thomas A 4
Accession 0001104659-23-105925
CIK 0001829635other
Filed
Oct 1, 8:00 PM ET
Accepted
Oct 2, 4:39 PM ET
Size
4.9 KB
Accession
0001104659-23-105925
Insider Transaction Report
Form 4
Fitzgerald Thomas A
DirectorVP, Chief Financial Officer
Transactions
- Purchase
Common Stock
2023-09-28$0.51/sh+49,350$25,169→ 56,318 total
Footnotes (2)
- [F1]Represents shares acquired pursuant to an underwritten public offering of common stock by the Issuer.
- [F2]Reported amount reflects a 1-for-20 reverse stock split of the Issuer's common stock, which became effective as of May 22, 2023.
Documents
Issuer
Transcode Therapeutics, Inc.
CIK 0001829635
Entity typeother
Related Parties
1- filerCIK 0001854168
Filing Metadata
- Form type
- 4
- Filed
- Oct 1, 8:00 PM ET
- Accepted
- Oct 2, 4:39 PM ET
- Size
- 4.9 KB